Mechanistic insights of inflammation and organ failure after trauma or critical illness
Mechanistic insights of inflammation and organ failure after trauma or critical illness
批准号:
10393782
负责人:
Yang Jin
金额:
$0.97万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-01 至 2024-03-31
关键词:
AcidsAcute Lung InjuryAdult Respiratory Distress SyndromeAlveolarAlveolar MacrophagesAnesthesia proceduresAspirate substanceBronchoalveolar Lavage FluidCaveolinsCellsCharacteristicsComplexCritical CareCritical IllnessDataDevelopmentDiagnosticDistressEdemaEndotheliumEpithelialEpithelial CellsEsophagusEventExposure toFundingHyperoxiaIn VitroInflammationInflammatoryInflammatory ResponseLungLung InflammationMacrophage ActivationMediatingMedicineMembrane MicrodomainsMicroRNAsModelingModificationMusNatural ImmunityOrgan failureOxygenPathogenesisPatientsPublishingReportingRespiratory FailureSignal TransductionSterilityStimulusStomachSyndromeTestingTherapeuticTrainingTraumaWagesWorkalveolar epitheliumbasecaveolin 1extracellular vesiclesfallsin vivoinsightintercellular communicationmicrovesiclesmigrationmortalitynovelpost-traumarecruitsevere injurysupplemental oxygensystemic inflammatory responseundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract/Summary
Aspiration of non-infectious gastro-esophageal contents and/or exposure to high concentrations of
supplemental oxygen are common events in trauma, anesthetized and/or other critically ill patients. Some of
these patients will develop a more serious and protracted pulmonary or systemic inflammatory response
leading to acute lung injury (ALI) or worse, acute respiratory distress syndrome (ARDS). Despite recent
advances in critical care medicine, overall mortality from ARDS remains unacceptably high, reflecting the lack
of specific therapies. Currently, the pathogenesis of this devastating syndrome remains incompletely
understood, particularly after the “non-infectious” or “sterile” stimuli as mentioned above. The characteristic
features of ALI/ARDS include an intense inflammatory response, severe injury to the epithelial / endothelial
barrier and alveolar edema. Recent evidence suggests that type I alveolar epithelial (ATI) cell have previously
unrecognized functions in innate immunity and are underappreciated players in lung cellcell cross-talk. Based
on our published and preliminary data, we propose that ATI cell-derived microvesicles (ATI-MVs) mediate the
intercellular communication between ATI cells and alveolar macrophages (AMs) by the shuttling of selective
miRNAs, thus broadcasting distress signals to the recipient cells and initiating the inflammatory cascades. In
our previous work, we have reported that epithelial extracellular vesicles (EVs) are inducible and detectable in
both mouse broncho-alveolar lavage fluid (BALF). After exposure to aspirated acid or hyperoxia (sterile model
of ALI), most of the induced EVs originate from living ATI epithelial cells and fall into the range of microvesicles
(MVs). We further showed that MV-shuttling miRNAs promoted classic macrophage activation and migration in
vitro and lung inflammation in vivo. Lipid raft protein caveolin-1 (cav-1) facilitates the selection of miRNA
complex in the MVs. Based on our published and the supporting data, we hypothesize that the type I alveolar
epithelial MVs mediate non-infectious stimuli-associated inflammation via promoting macrophage activation
and recruitment through MV-miRNAs. We also hypothesize that the stimuli-induced cav-1 / hnRNPA2B1
interaction and modification regulate the incorporation of selective miRNAs into MVs. We will test our
hypotheses in the following specific aims. In aim I: we will characterize the secretion of MV-miRNAs and their
target cells in the presence of non-infectious stimuli. In aim II, we will determine the mechanisms of the miRNA
selection in MVs. In aim III, we will determine the functions of MV-miRNAs after non-infectious stimuli.
This current application is a supplemental proposal to request funds for an undergraduate student who
will be trained by us in summer and working on this project from June to August 2021.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
LncRNA regulates lung inflammation
-
批准号:10434036
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
LncRNA regulates lung inflammation
-
批准号:10205157
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
LncRNA regulates lung inflammation
-
批准号:10001992
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2019
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights of inflammation and organ failure after trauma or critical illness
-
批准号:9894815
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2018
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights into the systemic inflammation and organ failure in sepsis
-
批准号:9063433
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2014
-
负责人:Yang Jin
-
依托单位:
Mechanistic insights into the systemic inflammation and organ failure in sepsis
-
批准号:9276750
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2014
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8107341
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8645699
-
项目类别:
-
资助金额:$42.96万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8265608
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:8431403
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Cross talk between cav-1 and flot1 in lung injury
-
批准号:9181729
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2011
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7664946
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7260355
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7478544
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and function of Cyr61 in hyperoxia induced acute lung injury
-
批准号:7904906
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation Cyr61 in hyperoxia induced acute lung injury
-
批准号:7138358
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2006
-
负责人:Yang Jin
-
依托单位:
Regulation and Function Cyr61 in Acute Lung Injury
-
批准号:6995914
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2005
-
负责人:Yang Jin
-
依托单位:
海外基金